Back to results
CompletedPhase 4

Wellbutrin XL for Dysthymic Disorder

NCT00225251

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Mood Disorders Research Program, St. Luke's-Roosevelt Hospital Center

New York, New York, United States

View on ClinicalTrials.gov
Wellbutrin XL for Dysthymic Disorder — TrialFind